[ET Net News Agency, 9 January 2020] Nomura raised its target price for China Life
Insurance (02628) to HK$25.14 from HK$22.82 and maintained its "buy" rating.
The research house raised its FY2020 NBV (new business value) growth forecast to 11%
from 6%, as China Life's 2020 open year sales should be strong. China Life launched 2020
open year pre-sales in October 20'19, earlier than its key peers; and it achieved its open
year pre-sales target by mid-November 2019, according to guidance.
After pre-sales, the company is now focusing on both savings and protection products,
and thus Nomura expects a slight increase in the NBV margin for FY2020.
In addition, after strong agency force expansion in FY2019, China Life will focus more
on improving agency productivity. Nomura expects a slight agency headcount increase in
FY2020. (KL)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02628 CHINA LIFE
Nominal 
10.300 +0.180 (+1.779%) Research Report
09/01/2020 15:24
{I-bank focus}Nomura raises China Life (02628) to HK$25.14
| Remark: | Real time quote last updated: 26/04/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |